ArticleJournal of experimental & clinical cancer research : CR2025

FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer.

Junyao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.